BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38058825)

  • 1. LINC02362/hsa-miR-18a-5p/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma.
    Quan B; Liu W; Yao F; Li M; Tang B; Li J; Ren Z; Yin X
    Am J Cancer Res; 2023; 13(11):5590-5609. PubMed ID: 38058825
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Li D; Zhou T; Li Y; Xu Y; Cheng X; Chen J; Zheng WV
    Aging (Albany NY); 2022 Jan; 14(1):368-388. PubMed ID: 34990401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cuproptosis-Related MiR-21-5p/FDX1 Axis in Clear Cell Renal Cell Carcinoma and Its Potential Impact on Tumor Microenvironment.
    Xie M; Cheng B; Yu S; He Y; Cao Y; Zhou T; Han K; Dai R; Wang R
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
    Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
    BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.
    Chen S; Zhang Y; Ding X; Li W
    Front Genet; 2022; 13():838869. PubMed ID: 35386284
    [No Abstract]   [Full Text] [Related]  

  • 6. MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3.
    Cui M; Qu F; Wang L; Cheng D; Liu X
    Technol Cancer Res Treat; 2021; 20():15330338211043976. PubMed ID: 34738854
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor cuproptosis and immune infiltration improve survival of patients with hepatocellular carcinoma with a high expression of ferredoxin 1.
    Quan Y; Li W; Yan R; Cheng J; Xu H; Chen L
    Front Oncol; 2023; 13():1168769. PubMed ID: 37361595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
    Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
    Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA RP5-833A20.1 Suppresses Tumorigenesis In Hepatocellular Carcinoma Through Akt/ERK Pathway By Targeting miR-18a-5p.
    Chen Z; Ma Y; Pan Y; Zuo S; Zhu H; Yu C; Zhu C; Sun C
    Onco Targets Ther; 2019; 12():10717-10726. PubMed ID: 31827329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the hsa_circ_0039466/miR-96-5p/FOXO1 regulatory network in hepatocellular carcinoma by whole-transcriptome analysis.
    Yuan F; Tang Y; Cao M; Ren Y; Li Y; Yang G; Ou Q; Tustumi F; Levi Sandri GB; Raissi D; Pocha C; Deng M; Yao Z
    Ann Transl Med; 2022 Jul; 10(14):769. PubMed ID: 35965793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA PCGEM1 mediates oxaliplatin resistance in hepatocellular carcinoma via miR-129-5p/ETV1 axis in vitro.
    Chen J; Yuan D; Hao Q; Zhu D; Chen Z
    Adv Clin Exp Med; 2021 Aug; 30(8):831-838. PubMed ID: 34286514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA linc00467 plays an oncogenic role in hepatocellular carcinoma by regulating the miR-18a-5p/NEDD9 axis.
    Zheng Y; Nie P; Xu S
    J Cell Biochem; 2020 Jun; 121(5-6):3135-3144. PubMed ID: 31916278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cuproptosis-related gene signature and associated regulatory axis in stomach adenocarcinoma based on bioinformatics analysis.
    Ding D; Wang D; Qin Y
    Medicine (Baltimore); 2023 Jul; 102(30):e34230. PubMed ID: 37505170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA LINC01189 is associated with HCV-hepatocellular carcinoma and regulates cancer cell proliferation and chemoresistance through hsa-miR-155-5p.
    Yao Y; Shu F; Wang F; Wang X; Guo Z; Wang H; Li L; Lv H
    Ann Hepatol; 2021; 22():100269. PubMed ID: 33059056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hsa_circ_0001955 Enhances
    Ding B; Fan W; Lou W
    Mol Ther Nucleic Acids; 2020 Dec; 22():445-455. PubMed ID: 33230448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of onco-miRNAs in hepatocellular carcinoma and analysis of their regulatory network].
    Ye J; Xu W; Chen T
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):45-54. PubMed ID: 35249869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer.
    Jiang B; Zhu H; Feng W; Wan Z; Qi X; He R; Xie L; Li Y
    Dis Markers; 2022; 2022():9004830. PubMed ID: 36312586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a cuproptosis and copper metabolism gene-related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma.
    Yuan W; Xiao JH; Zhang JS; Mao BL; Wang PZ; Wang BL
    Front Oncol; 2023; 13():1153353. PubMed ID: 37056336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of serum miR-18a-5p in severe COVID-19 Egyptian patients.
    Haroun RA; Osman WH; Eessa AM
    J Genet Eng Biotechnol; 2023 Nov; 21(1):114. PubMed ID: 37953403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa-circ-0000098 promotes the progression of hepatocellular carcinoma by regulation of miR-136-5p/MMP2 axis.
    Cheng Y
    Adv Clin Exp Med; 2023 Jun; 32(6):689-700. PubMed ID: 36881359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.